Development of anti-virulence drugs by targeting the SaeRS two component system of Staphylococcus aureusBAE, TAEOKNational Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R21AI121664-02), $165,974USD, 12/01/2016 -- 05/31/2018